Metastatic Human Rhabdomyosarcoma: Molecular/Cellular and Cytogenetic Analysis of a Novel Cellular Model

Invasion and Metastasis

Volumn 16, Issue 2, 1996, Pages 83-96

  Kalebie, Thea ^a   Judde, Jean Gabriel ^a   Velez Yanguas, Maria ^a   Knutsen, Turid ^a   Helman, Lee J ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Rhabdomyosarcoma

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GENETICS; CARCINOMA; CYTOGENETICS; DIPLOIDY; HUMAN; HUMAN CELL; MELANOMA; MESENCHYMOMA; METASTASIS; MOLECULAR BIOLOGY; MOUSE; NONHUMAN; PHENOTYPE; PROMOTER REGION; REPORTER GENE; RHABDOMYOSARCOMA;

ANIMALS; CELL DIVISION; DIPLOIDY; GELATINASES; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, REPORTER; HUMANS; MATRIX METALLOPROTEINASE 2; METALLOENDOPEPTIDASES; MICE; MICE, NUDE; NEOPLASM METASTASIS; NEOPLASM PROTEINS; NEOPLASM TRANSPLANTATION; POLYPLOIDY; PROMOTER REGIONS (GENETICS); RECOMBINANT FUSION PROTEINS; RHABDOMYOSARCOMA; TRANSFECTION;

EID: 0030477145     PISSN: 02511789     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Liotta LA, Wewer U, Rao NC: Biochemical mechanisms of tumor invasion and metastasis. Anticancer Drug Res 1987;2:195-202.
2. Nicolson GL: Organ specificity of tumor metastasis: Role of preferential adhesion, invasion, and growth of malignant cells at specific secondary sites. Cancer Metastasis Rev 1988;7:143-188.
3. Tarin D, Matsumura Y: Recent advances in the study of tumour invasion and metastasis. J Clin Pathol 1994;47:385-390.
4. Kalebic T, Garbissa S, Glaser B, Liotta LA: Basement membrane collagen; degradation by migrating endothelial cells. Science 1983;221:281-283.
5. Berstein LR, Liotta LA: Molecular mediators of interactions with extracellular matrix components in metastasis and angiogenesis. Curr Opin Oncol 1994;6:106-113.
6. Opdenakker G, Van Damme J: Cytokines and proteases in invasive processes: Molecular similarities between inflammation and cancer. Cytokine 1992;4:251-258.
7. Bortner DM, Langer SJ, Ostrowski MC: Non-nuclear oncogenes and the regulation of gene expression in transformed cells. Crit Rev Oncog 1993;4:137-160.
8. Bishop JM: Molecular themes in oncogenesis. Cell 1991;64:235-248.
9. Matrisian LM, McDonnell S, Miller DB, Navre M, Seftor EA, Hendrix MJ: The role of the matrix metalloproteinase stromelysin in the progression of squamous cell carcinomas. Am J Med Sci 1991;302:157-162.
10. Pohl J, Radler-Pohl A, Schirrmacher V: A model to account for the effects of oncogenes, TPA, and retinoic acid on the regulation of genes involved in metastasis. Cancer Metastasis Rev 1988;7:347-356.
11. Stetler-Stevenson WG: Dont's know yet. Annu Rev Cell Biol 1993;9:541-573.
12. Liotta LA, Steeg PS, Stetler-Stevenson WG: Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation. Cell 1991;64:327-336.
13. Fidler IJ, Hart IR: Biological diversity in metastatic neoplasms: Origins and implications. Science 1982;217:998-1003.
14. Hart I, Fidler IJ: Implications of tumor heterogeneity for studies on the biology and therapy of cancer metastasis. Biochim Biophys Acta 1981;651:37-50.
15. Kalebic T, Williams JE, Talmadge JE, Kao-Shan C, Locklear K, Siegel GP, Liotta LA, Sobel ME, Steeg P: A novel method for selection of invasive tumor cells: Derivation and characterization of highly metastatic K-1735 melanoma cell line based on in vitro and in vivo invasive capacity. Clin Exp Metastasis 1988;6:301-318.
16. Leone A, Flatow U, King CR, Sandeen MA, Margulies IM, Liotta LA, Steeg PS: Reduced tumor incidence, metastatic potential, and cytokine responsiveness of nm23-transfected melanoma cells. Cell 1991;65:25-35.
17. Poupon MF: From tumor cell to metastasis. Bull Cancer 1993;80:5-10.
18. Parham DM: The molecular biology of childhood rhabdomyosarcoma. Semin Diagn Pathol 1994;11:39-46.
19. McAllister RM, Melnyk J, Finkelstein J, Adams EC, Gardner MB: Cultivation in vitro of cells derived from a human rhabdomyosarcoma. Cancer 1969;24:520-526.
20. Geran RI, Greenberg NH, Macdonald MM, Schumacher AM, Abbott BJ: Protocols for screening chemical agents and natural products against animal tumors and other biological systems. Cancer Chemother Rep Pt III 1972;3:1-103.
21. Whang-Peng J, Knutsen T, Theil K, Horowitz ME, Triche T: Cytogenetic studies in subgroups of rhabdomyosarcoma. Genes Chromosom Cancer 1992;5:299-310.
22. Pennica D, Holmes WE, Kohr WJ, Harkins RN, Vehar GA, Ward CA, Bennett WF, Yelverton E, Seeburg PH, Heyneker HL: Cloning and expression of human tissue-type plasminogen activator. Nature 1983;301:214-221.
23. McCoy MS, Bargmann CI, Weinberg RA: Human colon carcinoma Ki-ras2 oncogene and its corresponding proto-oncogene. Mol Cell Biol 1984;4:1577-1582.
24. Thiele CJ, McKeon C, Triche TJ, Ross RA, Reynolds CP, Israel MA: Differential proto-oncogene expression characterizes histopathologically indistinguishable tumors of the peripheral nervous system. J Clin Invest 1987;80:804-811.
25. Felix CA, Chavez Kappel C, Mitsudomi T, Nau MM, Tsokos M, Crouch GD, Nisen PD, Winick NJ, Herman LJ: Frequency and diversity of p53 mutations in childhood rhabdomyosarcoma. Cancer Res 1992;52:2243-2247.
26. Edmondson DG, Olson EN: A gene with homology to the myc similarity region of MyoD1 is expressed during myogenesis and is sufficient to activate the muscle differentiation program. Genes Dev 1989;4:628-640.
27. El-Badry OM, Minniti CP, Kohn EC, Houghton PJ, Daughaday WH. Hehnan LJ: Insulin-like growth factor II acts as an autocrine growth and motility factor in human rhabdomyosarcoma tumors. Cell Growth Differ 1990;1:325-331.
28. Wacher MP, Krutzsch HC, Liotta LA, Stetler-Stevenson WG: Development of a novel substrate capture immunoassay for the detection of a neutral metalloprotease capable of degrading basement membrane (type IV) collagen. J Immunol Methods 1990;126:239-245.
29. Gorman CM, Moffat LF, Howard BH: Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol Cell Biol 1982;2:1044-1051.
30. Zeichner SL, Hirka G, Andrews PW, Alwine JC: Differentiation-dependent human immunodeficiency virus long-terminal-repeat regulatory elements active in human teratocarcinoma cells. J Virol 1992;66:2268-2273.
31. Jain VK, Magrath I: A chemilumimescent assay for quantitation of beta-galactosidase in the femotgram range: Application to quantitation of beta-galactosidase in LacZ-transfected cells. Anal Biochem 1991;199:119-124.
32. Wood KV: Recent advances and prospects for use of beetle luciferases as general reporter vectors; in Stanley P, Kricka L (eds): Bioluminescence and Chemiluminescence: Current Status. Chichester, Wiley, 1982, pp 543-548.
33. Dignam JD, Martin PL, Shastry BS, Roeder RG: Eukaryotic gene transcription with purified components. Methods Enzymol 1983;101:582-599.
34. Heppner GH: Tumor heterogeneity. Cancer Res 1984;214:2259-2265.
35. Fearson ER, Hamilton SR: Clonal analysis of human colorectal tumors. Science 1987;238:193-197.
36. Nicolson GL: Gene expression, cellular diversification and tumor progression. Bioessays 1991;13:337-342.
37. Shapiro DN, Parnham DM, Douglass EC, Ashmun R, Webber BL, Newton WA Jr., Hancock ML, Maurer HM, Look AT: Relationship of tumor-cell ploidy to histologic subtype and treatment outcome in children and adolescents with unresectable rhabdomyosarcoma. J Clin Oncol 1991;9:159-166.
38. Terranova VP, Rao CN, Kalebic T: Laminin receptor on human breast carcinoma cells. Proc Natl Acad Sci USA 1983;80:444-451.
39. Rifkin DB: Plasminogen activator expression and matrix degradation. Matrix Suppl 1992;1:20-22.
40. Kwaan HC: The plasminogen-plasmin system in malignancy. Cancer Metastasis Rev 1992;11:291-311.
41. Thorgeirsson UP, Turpeenniemi-Hujanen T, Williams JE, Westein EH, Heilman CA, Talmadge JE, Liotta LA: NIH/3T3 cells transfected with human tumor DNA containing activated ras oncogenes express the metastatic phenotype in nude mice. Mol Cell Biol 1985;5:259-262.
42. Greenberg AH, Egen SE,Wright JA: Oncogenes and metastatic progression. Invasion Metastasis 1989;9:360-378.
43. Nicolson GL: Molecular mechanisms of cancer metastasis: Tumor and host properties and the role of oncogenes and suppressor genes. Curr Opin Oncol 1991;3:75-92.
44. Kozma L, Kiss I, Szakall S, Ember I: Investigation of c-myc oncogene amplification in colorectal cancer. Cancer Lett 1994;81:165-169.
45. Volm M, van Kaick G, Mattern J: Analysis of c-fos, c-jun, c-erbB1, and c-myc in primary lung carcinomas and their lymph node metastases. Clin Exp Metastasis 1994;12:329-334.
46. Steeg PS, Bevilacqua G, Rosengard AM: Altered gene expression in tumor metastasis: The main mn23 gene; in Schirrmacher V, Schwartz-Albiez R (eds): Cancer Metastasis: Molecular and Cellular Biology, Host Immune Responses, and Perspective for Treatment. Berlin, Springer, 1989, pp 48-52.
47. Sobel ME: Metastasis suppressor genes. J Natl Cancer Inst 1990;82:267-276.
48. Inoue M, Okayama A, Fujita M, Enomoto T, Sakata M, Tanizawa O, Ueshima H: Clinicopathological characteristics of p53 overexpression in endometrial cancers. Int J Cancer 1994;58:14-19.
49. Stetler-Stevenson WG: Type-IV collagenase in tumor invasion and metastasis. Cancer Metastasis Rev 1990;9:289-303.
50. Aznavoorian S, Murphy AN, Stetler-Stevenson WG, Liotta LA: Molecular aspects of tumor cell invasion and metastasis. Cancer 1993;71:1368-1383.
51. Davis RL, Weintraub H, Lassar AB: Expression of a single transfected cDNA converts fibroblasts to myoblasts. Cell 1987;51:987-1000.
52. Kalebic T, Tsokos M, Helman LJ: In vivo treatment with antibody against IGF-I receptor suppresses growth of human rhabdomyosarcoma and down regulates p34cdc2. Cancer Res 1994;54:5531-5534.